Contrarian Opportunity
Search documents
Banks Are Unanimously Bearish On Oil – Is It The Contrarian Opportunity For 2026?
Yahoo Finance· 2025-12-29 13:31
Oil is closing 2025 as one of the negative-performing assets. Despite starting the year with a rally, oil's movement soon became typical bear-market dynamics. Consistent price decline interrupted by volatile, sharp double-digit rallies. Still, even in that environment, oil majors saw significant performance discrepancies. ConocoPhillips (NYSE:COP) lost 8.3% year-to-date, while Exxon Mobil (NYSE:XOM) squeezed a double-digit gain of over 11%. Going into 2026, oil has become one of the most consensus-bearis ...
Banks Are Unanimously Bearish On Oil – Is It The Contrarian Opportunity For 2026? - ConocoPhillips (NYSE:COP), United States Oil Fund (ARCA:USO)
Benzinga· 2025-12-28 18:30
Oil is closing 2025 as one of the negative-performing assets. Despite starting the year with a rally, oil's movement soon became typical bear-market dynamics. Consistent price decline interrupted by volatile, sharp double-digit rallies.Still, even in that environment, oil majors saw significant performance discrepancies. ConocoPhillips (NYSE:COP) lost 8.3% year-to-date, while Exxon Mobil (NYSE:XOM) squeezed a double-digit gain of over 11%.Going into 2026, oil has become one of the most consensus-bearish ass ...
Community Health Systems: Stock Tanks On Q2 Earnings, CEO Retires - I Sense A Contrarian Opportunity
Seeking Alpha· 2025-07-24 21:34
Group 1 - Community Health Systems (NYSE: CYH) reported Q2 2025 earnings, leading to a significant stock sell-off of nearly 30%, with shares trading around $2.75, resulting in a market capitalization of approximately $385 million [1] - The investing group Haggerston BioHealth provides insights into the biotech, pharma, and healthcare sectors, offering catalysts, buy and sell ratings, product sales forecasts, and detailed financial analyses [1] - Analyst Edmund Ingham has extensive experience in biotech consulting, having covered over 1,000 companies in the healthcare and pharma sectors [1]